1-3 of 3
John W. Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Fabrice André, Thomas Bachelot, Mario Campone, Florence Dalenc, Jose M. Perez-Garcia, Sara A. Hurvitz, Nicholas Turner, Hope Rugo, John W. Smith, Stephanie Deudon, Michael Shi, Yong Zhang, Andrea Kay, Diana Graus Porta, Alejandro Yovine, José Baselga
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3693–3702.
https://doi.org/10.1158/1078-0432.CCR-13-0190
Published: 30 June 2013
View article titled, Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
Open the PDF for Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer

Kim Margolin, Michael B. Atkins, Janice P. Dutcher, Marc S. Ernstoff, John W. Smith, II, Joseph I. Clark, Joseph Baar, Jeffrey Sosman, Jeffrey Weber, Chetan Lathia, Janice Brunetti, Frank Cihon, Brian Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3312–3319.
https://doi.org/10.1158/1078-0432.CCR-06-1341
Published: 01 June 2007
View article titled, Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer
Open the PDF for Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer in another window
Journal Articles

gp100209–2M Peptide Immunization of Human Lymphocyte Antigen-A2+ Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8+ T Cells

Edwin B. Walker, Daniel Haley, William Miller, Kevin Floyd, Ketura P. Wisner, Nelson Sanjuan, Holden Maecker, Pedro Romero, Hong-Ming Hu, W. Gregory Alvord, John W. Smith, II, Bernard A. Fox, Walter J. Urba
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (2): 668–680.
https://doi.org/10.1158/1078-0432.CCR-0095-03
Published: 03 February 2004
View article titled, gp100<sub>209–2M</sub> Peptide Immunization of Human Lymphocyte Antigen-A2<sup>+</sup> Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8<sup>+</sup> T Cells
Open the PDF for gp100<sub>209–2M</sub> Peptide Immunization of Human Lymphocyte Antigen-A2<sup>+</sup> Stage I-III Melanoma Patients Induces Significant Increase in Antigen-Specific Effector and Long-Term Memory CD8<sup>+</sup> T Cells in another window